Kopsavilkums
Familial hypercholesterolemia (FH) is a genetic disorder with well-known genetic transmission and clinical course. Despite great recent progress, FH is still underestimated, under-diagnosed and thus undertreated. Furthermore it represents a significant healthcare challenge as a common risk factor for the premature development of coronary heart disease. The ScreenPro FH Project is an international network project aiming at improving complex care - from timely screening, through diagnosis to up-to-date treatment of familial hypercholesterolemia in Central, Eastern and Southern Europe. An important task for the project is to harmonise and unify diagnostic and therapeutic approaches in participating countries, where the situation differs from country to country. Countries with more experience should serve as a model for countries developing the FH network.
| Oriģinālvaloda | Angļu |
|---|---|
| Lapas (no-līdz) | 43-48 |
| Lapu skaits | 6 |
| Žurnāls | Vnitrni Lekarstvi |
| Sējums | 63 |
| Izdevuma numurs | 1 |
| Publikācijas statuss | Publicēts - 2017 |
| Ārēji publicēts | Jā |
ANO IAM
Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)
-
3. IAM — Laba Veselība un Labbūtība
OECD Zinātnes nozare
- 3. Medicīnas un veselības zinātnes
Nospiedums
Uzziniet vairāk par pētniecības tēmām “ScreenPro FH - Screening project for familial hypercholesterolemia in central, southern and eastern Europe: Rationale and design”. Kopā tie veido unikālu nospiedumu.Citēt šo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver